Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Retinoids may help treat lupus nephritis and reduce steroid use.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Cinainu is effective and safe for treating children's alopecia areata.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Clascoterone safely promotes hair growth similar to minoxidil.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A semi-automated system can effectively help choose emulsion ingredients, simplifying the creation of medicinal and cosmetic products.

The combination treatment showed a higher response rate but no significant survival benefits.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.